Evidence map›Paper›PMID 33222116›Full record

ArticleInternal and emergency medicine2021

Effectiveness and safety of noninvasive positive pressure ventilation in the treatment of COVID-19-associated acute hypoxemic respiratory failure: a single center, non-ICU setting experience.

Antonio Faraone, Chiara Beltrame, Andrea Crociani, Paolo Carrai, Elena Lovicu, Simona Filetti, Serena Sbaragli, Chiara Alessi, Michela Cameron Smith, Chiara Angotti and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Internal and emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Antonio FaraoneDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy. antonio.faraone@uslcentro.toscana.it.ORCID 0000-0001-6095-8403
Chiara BeltrameDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Andrea CrocianiDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Paolo CarraiDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Elena LovicuDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Simona FilettiDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Serena SbaragliDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Chiara AlessiDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Michela Cameron SmithDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Chiara AngottiDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Alberto FortiniDepartment of Internal Medicine, San Giovanni Di Dio Hospital, Via di Torregalli 3, 50143, Florence, Italy.
Nuovo Ospedale San Giovanni di Dio · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of noninvasive positive pressure ventilation (NIPPV) in COVID-19 patients with acute hypoxemic respiratory failure (AHRF) is uncertain, as no direct evidence exists to support NIPPV use in such patients. We retrospectively assessed the effectiveness and safety of NIPPV in a cohort of COVID-19 patients consecutively admitted to the COVID-19 general wards of a medium-size Italian hospital, from March 6 to May 7, 2020. Healthcare workers (HCWs) caring for COVID-19 patients were monitored, undergoing nasopharyngeal swab for SARS-CoV-2 in case of onset of COVID-19 symptoms, and periodic SARS-CoV-2 screening serology. Overall, 50 patients (mean age 74.6 years) received NIPPV, of which 22 (44%) were successfully weaned, avoiding endotracheal intubation (ETI) and AHRF-related death. Due to limited life expectancy, 25 (50%) of 50 NIPPV-treated patients received a "do not intubate" (DNI) order. Among these, only 6 (24%) were weaned from NIPPV. Of the remaining 25 NIPPV-treated patients without treatment limitations, 16 (64%) were successfully weaned, 9 (36%) underwent delayed ETI and, of these, 3 (33.3%) died. NIPPV success was predicted by the use of corticosteroids (OR 15.4, CI 1.79-132.57, p 0.013) and the increase in the PaO

Indexed as

AgedAged, 80 and overChi-Square DistributionCOVID-19FemaleHumansInfection ControlMaleMiddle AgedMultivariate AnalysisNoninvasive VentilationOrgan Dysfunction ScoresPositive-Pressure RespirationRespiratory InsufficiencyRespiratory MechanicsRetrospective StudiesadultAerosol-generating proceduresCOVID-19Health personnelNoninvasive ventilationPersonal protective equipmentRespiratory distress syndrome

Identifiers

PMID33222116
PMCPMC7680552
OpenAlexW3106950343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.